129 related articles for article (PubMed ID: 1417009)
1. [Aminoglutethimide and aminoglutethimide+tamoxifen treatment for advanced breast cancer].
Hisamatsu K; Nomura Y; Tashiro H
Gan To Kagaku Ryoho; 1992 Oct; 19(12):2017-23. PubMed ID: 1417009
[TBL] [Abstract][Full Text] [Related]
2. Progress report on two clinical trials in women with advanced breast cancer. Trial I: tamoxifen versus tamoxifen plus aminoglutethimide. Trial II: aminoglutethimide in patients with prior tamoxifen exposure.
Ingle JN; Green SJ; Ahmann DL; Edmonson JH; Nichols WC; Frytak S; Rubin J
Cancer Res; 1982 Aug; 42(8 Suppl):3461s-3467s. PubMed ID: 7044529
[TBL] [Abstract][Full Text] [Related]
3. Tamoxifen and aminoglutethimide in advanced breast cancer.
Corkery J; Leonard RC; Henderson IC; Gelman RS; Hourihan J; Ascoli DM; Salhanick HA
Cancer Res; 1982 Aug; 42(8 Suppl):3409s-3414s. PubMed ID: 7044523
[TBL] [Abstract][Full Text] [Related]
4. Tamoxifen versus aminoglutethimide versus combined tamoxifen and aminoglutethimide in the treatment of advanced breast carcinoma.
Smith IE; Harris AL; Morgan M; Gazet JC; McKinna JA
Cancer Res; 1982 Aug; 42(8 Suppl):3430s-3433s. PubMed ID: 7044525
[TBL] [Abstract][Full Text] [Related]
5. Use of aminoglutethimide as second-line endocrine therapy in metastatic breast cancer.
Kaye SB; Woods RL; Fox RM; Coates AS; Tattersall MH
Cancer Res; 1982 Aug; 42(8 Suppl):3445s-3447s. PubMed ID: 6177404
[TBL] [Abstract][Full Text] [Related]
6. Combined endocrine treatment of postmenopausal patients with advanced breast cancer. A randomized trial of tamoxifen vs. tamoxifen plus aminoglutethimide and hydrocortisone.
Rose C; Kamby C; Mouridsen HT; Bastholt L; Brincker H; Skovgaard-Poulsen H; Andersen AP; Loft H; Dombernowsky P; Andersen KW
Breast Cancer Res Treat; 1986; 7 Suppl():S45-50. PubMed ID: 3527306
[TBL] [Abstract][Full Text] [Related]
7. Aminoglutethimide in the treatment of advanced postmenopausal breast cancer.
Harris AL; Powles TJ; Smith IE
Cancer Res; 1982 Aug; 42(8 Suppl):3405s-3408s. PubMed ID: 7083207
[TBL] [Abstract][Full Text] [Related]
8. Effects of aminoglutethimide plus hydrocortisone on the genital tract of postmenopausal women with advanced breast cancer. A clinical and cytologic survey.
Budel VM; Paridaens RJ; Spetschinsky A; Heuson JC; Gompel C
Anticancer Res; 1986; 6(4):709-12. PubMed ID: 3752949
[TBL] [Abstract][Full Text] [Related]
9. Aminoglutethimide after tamoxifen therapy in advanced breast cancer: M. D. Anderson Hospital experience.
Buzdar AU; Powell KC; Blumenschein GR
Cancer Res; 1982 Aug; 42(8 Suppl):3448s-3450s. PubMed ID: 7083209
[TBL] [Abstract][Full Text] [Related]
10. Trial of aminoglutethimide vs hydrocortisone as second-line hormone treatment of advanced breast cancer.
Mercer PM; Ebbs SR; Fraser SC; Coltart RS; Bates T
Eur J Surg Oncol; 1993 Jun; 19(3):254-8. PubMed ID: 8314383
[TBL] [Abstract][Full Text] [Related]
11. [Clinical evaluation of NK 622 (toremifene citrate) in advanced or recurrent breast cancer--a comparative study by a double blind method with tamoxifen].
Nomura Y; Tominaga T; Abe O; Izuo M; Ogawa N
Gan To Kagaku Ryoho; 1993 Feb; 20(2):247-58. PubMed ID: 8434963
[TBL] [Abstract][Full Text] [Related]
12. Phase II study of aminoglutethimide and medroxyprogesterone acetate in the treatment of patients with advanced breast cancer.
Nagel GA; Wander HE; Blossey HC
Cancer Res; 1982 Aug; 42(8 Suppl):3442s-3444s. PubMed ID: 6123383
[TBL] [Abstract][Full Text] [Related]
13. [2d and 3d line hormonal therapy in postmenopausal metastatic breast tumor. Comparison of medroxyprogesterone acetate and aminoglutethimide in tamoxifen-resistant patients].
Garcia-Giralt E; Omodei Zorini C; Ferri L; Ayme Y; Carton M; Daban A; Delozier T; Fargeot P; Fumoleau P; Gorins A
Clin Ter; 1994 Aug; 145(8):113-21. PubMed ID: 7955956
[TBL] [Abstract][Full Text] [Related]
14. [Antiestrogens in the treatment of advanced breast cancer].
Płuzańska A; Smiałowska A; Stempczyńska J; Wator A
Pol Tyg Lek; 1989 Feb 13-20; 44(7-8):191-4. PubMed ID: 2813178
[TBL] [Abstract][Full Text] [Related]
15. Aminoglutethimide in tamoxifen-resistant patients: The Melbourne Experience.
Murray RM; Pitt P
Cancer Res; 1982 Aug; 42(8 Suppl):3437s-3441s. PubMed ID: 6211229
[TBL] [Abstract][Full Text] [Related]
16. Aminoglutethimide as second line endocrine therapy in advanced breast cancer.
Brufman G; Biran S
Anticancer Res; 1986; 6(5):1065-8. PubMed ID: 3800315
[TBL] [Abstract][Full Text] [Related]
17. Aminoglutethimide as second line therapy in advanced breast cancer.
Elomaa I; Blomqvist C; Rissanen P
Breast Cancer Res Treat; 1986; 7 Suppl():S51-4. PubMed ID: 3017481
[TBL] [Abstract][Full Text] [Related]
18. Treatment of metastatic breast cancer with aminoglutethimide after progression on chemotherapy and/or hormonal therapy with tamoxifen.
Brufman G; Biran S
Eur J Surg Oncol; 1985 Mar; 11(1):27-31. PubMed ID: 2985452
[TBL] [Abstract][Full Text] [Related]
19. [A comparative study among ftorafur, ftorafur plus tamoxifen, and tamoxifen in adjuvant therapy for breast cancer. The Chubu Cooperative Study Group of Adjuvant Chemoendocrine Therapy for Breast Cancer, Japan].
Yoshida M; Saji S; Takagi H; Takeuchi S; Tsuda H; Nimura Y; Mizumoto R; Miyazaki I; Kobayashi S; Noguchi M
Gan To Kagaku Ryoho; 1993 Dec; 20(15):2325-33. PubMed ID: 8259846
[TBL] [Abstract][Full Text] [Related]
20. Randomized trial of tamoxifen alone or combined with aminoglutethimide and hydrocortisone in women with metastatic breast cancer.
Ingle JN; Green SJ; Ahmann DL; Long HJ; Edmonson JH; Rubin J; Chang MN; Creagan ET
J Clin Oncol; 1986 Jun; 4(6):958-64. PubMed ID: 3519885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
